케어젠

214370KOSDAQ기초 의약물질 제조업

46.0 / 100

Reference Date: 2026-06-10

Financial Score11.5 / 40

News Sentiment18.5 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 23.8% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Caregen develops and sells pharmaceuticals, health supplements, medical devices, and cosmetics based on biomimetic peptides and growth factor proteins, leveraging a large peptide library with over 860 patents. The company offers key products such as blood sugar regulators, muscle health supplements, and weight management solutions, and is expanding into new drug pipelines for conditions like macular degeneration, diabetes, and hair loss through global sales in 130 countries.

Number of Employees

201people

Average Salary

50.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

181.27Industry Average 27.710.0Point

6.5x industry avg (risky)

PBR

18.83Industry Average 1.740.0Point

10.8x industry avg (risky)

ROE

9.23Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

4.90Industry Average 6.625.0Point

Lower than industry avg (good)

Trend 2023~20253.0 / 10 points

Revenue Growth Rate

0.5 / 3

Avg ▼3.8% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼27.8% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 13.9% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 3Neutral 1Negative 2Average Sentiment Score 74.2

Negative
케어젠, 탈모·발모 제품 해외 공급계약 2건 해지…총 399억원 규모
케어젠의 해외 공급계약 해지로 인해 재무적 손실이 발생하여 부정적 영향이 예상됩니다.
Neutral
"번뜩이는 아이디어로 혁신"…첫 '여성 발명왕' 탄생
발명의 날에서 여성 발명가 선정은 긍정적이지만, 케어젠과 직접적인 연관성이 없어 중립적 평가.
Positive
[속보]코스피, 매수 사이드카 발동…장초반 7500선
코스피 지수의 급등으로 케어젠 포함 주요 종목들의 긍정적인 시장 분위기가 형성되었다.

Detailed Momentum

52-week position3.0Point

52w lower range (36%)

Current 74,500Won52-week high 150,10052-week low 30,250

1-month return0.0Point

1m -23.75% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral단일판매ㆍ공급계약해지(자율공시)2026-05-29
Neutral단일판매ㆍ공급계약해지2026-05-29
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-27
Neutral주식등의대량보유상황보고서(일반)2026-05-21
Neutral분기보고서 (2026.03)2026-05-13